Navigation Links
Medarex to Present at the Susquehanna Financial Group Healthcare Conference
Date:2/28/2008

PRINCETON, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it is scheduled to present at the Susquehanna Financial Group Second Annual SIGnificant Investment Options in Healthcare Conference at 3:00 p.m. ET on Wednesday, March 5, 2008, in New York. The event will be webcast live and will be available in the Investor Relations section of the Medarex website at http://www.medarex.com. An archived edition of the presentation will be available following the event.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. Over forty of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trad
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
2. Medarex Announces Completion of Sale of Shares in Genmab A/S
3. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
4. Medarex Announces Election of Marc Rubin as New Board Member
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
7. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
8. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
9. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
10. InterMune to Present at the SIGnificant Options in Healthcare Conference
11. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... FREMONT, Calif., June 16 Microfluidic Systems, a ... number 7,541,166, entitled "Sonication to Selectively Lyse Different ... process of differential extraction of male/female DNA from ... a wide variety of biological sample processes for ...
... experts to present best practices for improving drug safety and ... June 16 Covance Inc. is pleased to announce the ... Drug Information Association,s (DIA) 45th Annual Meeting ... , , The DIA Annual Meeting is the ...
... Six prestigious members of the National Institutes of Health ... ), the nation,s leading online jobs board and careers ... NIH has the highest number of post-doctoral professionals at ... organizations that have joined include the National Institute of ...
Cached Biology Technology:MicroFluidic Systems (MFSI) Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis. 2Covance to Present at the Drug Information Association's 45th Annual Meeting 2Covance to Present at the Drug Information Association's 45th Annual Meeting 3Covance to Present at the Drug Information Association's 45th Annual Meeting 4Covance to Present at the Drug Information Association's 45th Annual Meeting 5National Institutes of Health Join Nation's Leading Postgrad Bio Jobs Board 2National Institutes of Health Join Nation's Leading Postgrad Bio Jobs Board 3
(Date:4/15/2014)... temperatures in the Congo Basin to increase by ... by greenhouse gases by half, according to a ... Belgium. , Explosive population growth and inefficient agricultural ... in Central Africa. A team of researchers from ... will affect longer-term temperatures in the region. Using ...
(Date:4/15/2014)... systems soon could be powering the forklifts used in ... with faster refueling times than ever before, courtesy of ... Carriers (HHC). , The goal of the project is ... refuel at low pressure four to five times faster ... hydrogen a competitive advantage over batteries for a big ...
(Date:4/14/2014)... study of subarctic forest moths in Finnish Lapland suggests ... change on animals and plants because much of the ... populations of 80 moth species and found that 90 ... the study period, from 1978 to 2009. During that ... 3.5 degrees Fahrenheit, and winter precipitation increased as well. ...
Breaking Biology News(10 mins):Study: Deforestation could intensify climate change in Congo Basin by half 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4Moth study suggests hidden climate change impacts 2Moth study suggests hidden climate change impacts 3
... past 17 years for extracting oil is now at the ... Canada. Duvernay Petroleum is to use the revolutionary ... Bath at its site at Peace River in Alberta, Canada. ... like syrup, or even solid in its natural state underground, ...
... Singulex Inc. today announced,that it is collaborating ... the company,s Erenna(TM) system. Singulex has installed the,Erenna ... Technology Access Program,(ETAP) and has begun optimizing assays ... specific biomarkers in human blood., "Biomarkers play ...
... University of Liverpool have been awarded 5 million to investigate ... radiation. Biologists at Liverpool will investigate the role ... when to die. NFkB governs responses within cells to ... this system goes wrong it is thought that it can ...
Cached Biology News:Massive Canadian oilfield could be exploited using new UK system 2Massive Canadian oilfield could be exploited using new UK system 3Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design 2
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
... Immunogen: Peptide ... encompassing the human, mouse, and ... Accession Number: NM_000314 ... Routinely evaluated by immunoblot. ...
Mouse monoclonal [MN-8C4] to zona radiata ( Abpromise for all tested applications). Antigen: Purified eggshell proteins (zona radiata proteins and small amounts of zona pellucida proteins) from ...
Biology Products: